DK2850212T3 - Method of screening for colorectal cancer - Google Patents
Method of screening for colorectal cancer Download PDFInfo
- Publication number
- DK2850212T3 DK2850212T3 DK13790927.1T DK13790927T DK2850212T3 DK 2850212 T3 DK2850212 T3 DK 2850212T3 DK 13790927 T DK13790927 T DK 13790927T DK 2850212 T3 DK2850212 T3 DK 2850212T3
- Authority
- DK
- Denmark
- Prior art keywords
- screening
- colorectal cancer
- colorectal
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/10—Characterised by chemical treatment
- C12Q2523/125—Bisulfite(s)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Databases & Information Systems (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Data Mining & Analysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261648821P | 2012-05-18 | 2012-05-18 | |
| PCT/AU2013/000519 WO2013170314A1 (en) | 2012-05-18 | 2013-05-17 | A method of screening for colorectal cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2850212T3 true DK2850212T3 (en) | 2020-03-23 |
Family
ID=49582906
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13790927.1T DK2850212T3 (en) | 2012-05-18 | 2013-05-17 | Method of screening for colorectal cancer |
| DK19199179.3T DK3608421T3 (en) | 2012-05-18 | 2013-05-17 | Procedure for screening for colorectal cancer |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19199179.3T DK3608421T3 (en) | 2012-05-18 | 2013-05-17 | Procedure for screening for colorectal cancer |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10941449B2 (en) |
| EP (3) | EP2850212B1 (en) |
| AU (3) | AU2013262435B2 (en) |
| DK (2) | DK2850212T3 (en) |
| ES (1) | ES2778028T3 (en) |
| HK (1) | HK1208709A1 (en) |
| WO (1) | WO2013170314A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10526642B2 (en) * | 2011-08-25 | 2020-01-07 | Commonwealth Scientific And Industrial Research Organisation | DNA methylation in colorectal and breast cancer diagnostic methods |
| DK2847355T3 (en) | 2012-05-11 | 2019-10-14 | Clinical Genomics Pty Ltd | COLORECTAL CANCER DIAGNOSTIC GENERAL MARKING PANEL |
| KR102461235B1 (en) | 2014-06-04 | 2022-10-28 | 퀘스트 다이어그노스틱스 인베스트먼츠 인코포레이티드 | Methylated markers for colorectal cancer |
| US11514289B1 (en) * | 2016-03-09 | 2022-11-29 | Freenome Holdings, Inc. | Generating machine learning models using genetic data |
| CN112352057A (en) * | 2018-04-12 | 2021-02-09 | 鹍远基因公司 | Compositions and methods for cancer or neoplasia assessment |
| CN109371138B (en) * | 2018-12-29 | 2022-10-25 | 上海奕谱生物科技有限公司 | Methylation-modification-based tumor marker STAMP-EP4 |
| US11396679B2 (en) | 2019-05-31 | 2022-07-26 | Universal Diagnostics, S.L. | Detection of colorectal cancer |
| US11898199B2 (en) | 2019-11-11 | 2024-02-13 | Universal Diagnostics, S.A. | Detection of colorectal cancer and/or advanced adenomas |
| WO2021209161A1 (en) * | 2020-04-17 | 2021-10-21 | Universal Diagnostics, S.L. | Detection of advanced adenoma and/or early stage colorectal cancer |
| CN115997035A (en) | 2020-06-30 | 2023-04-21 | 通用诊断股份公司 | Systems and methods for detecting multiple cancer types |
| WO2022271730A1 (en) * | 2021-06-21 | 2022-12-29 | Guardant Health, Inc. | Methods and compositions for copy-number informed tissue-of-origin analysis |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4883750A (en) | 1984-12-13 | 1989-11-28 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
| AU622426B2 (en) | 1987-12-11 | 1992-04-09 | Abbott Laboratories | Assay using template-dependent nucleic acid probe reorganization |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US6033854A (en) | 1991-12-16 | 2000-03-07 | Biotronics Corporation | Quantitative PCR using blocking oligonucleotides |
| US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
| WO1995006137A1 (en) | 1993-08-27 | 1995-03-02 | Australian Red Cross Society | Detection of genes |
| US5830645A (en) | 1994-12-09 | 1998-11-03 | The Regents Of The University Of California | Comparative fluorescence hybridization to nucleic acid arrays |
| US5786146A (en) | 1996-06-03 | 1998-07-28 | The Johns Hopkins University School Of Medicine | Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids |
| DE69733282T2 (en) | 1996-06-04 | 2006-01-19 | University Of Utah Research Foundation, Salt Lake City | Monitoring hybridization during PCR |
| AU7164998A (en) | 1997-04-28 | 1998-11-24 | B-E Safe, Inc. | Taxonomic identification of microorganisms, proteins and peptides involved in vertebrate disease states |
| US6331393B1 (en) | 1999-05-14 | 2001-12-18 | University Of Southern California | Process for high-throughput DNA methylation analysis |
| US6180349B1 (en) | 1999-05-18 | 2001-01-30 | The Regents Of The University Of California | Quantitative PCR method to enumerate DNA copy number |
| DE10130800B4 (en) | 2001-06-22 | 2005-06-23 | Epigenomics Ag | Method for the detection of cytosine methylation with high sensitivity |
| ES2431944T3 (en) | 2002-06-26 | 2013-11-28 | Cold Spring Harbor Laboratory | Methods to determine methylation profiles |
| JP4453297B2 (en) | 2003-05-27 | 2010-04-21 | トヨタ自動車株式会社 | Planetary gear type multi-stage transmission for vehicles |
| US7901880B2 (en) | 2003-10-21 | 2011-03-08 | Orion Genomics Llc | Differential enzymatic fragmentation |
| WO2005085477A1 (en) | 2004-03-02 | 2005-09-15 | Orion Genomics Llc | Differential enzymatic fragmentation by whole genome amplification |
| US10927415B2 (en) | 2008-11-26 | 2021-02-23 | The Johns Hopkins University | Methods for identifying cancer risk |
| EP3034628B1 (en) * | 2010-09-13 | 2018-10-24 | Clinical Genomics Pty Ltd | Diagnosis of cancer by means of methylation marker |
| US10526642B2 (en) | 2011-08-25 | 2020-01-07 | Commonwealth Scientific And Industrial Research Organisation | DNA methylation in colorectal and breast cancer diagnostic methods |
| KR101599179B1 (en) | 2012-05-14 | 2016-03-02 | 후아웨이 테크놀러지 컴퍼니 리미티드 | Group communication method and system, group server and group member device |
-
2013
- 2013-05-17 DK DK13790927.1T patent/DK2850212T3/en active
- 2013-05-17 ES ES13790927T patent/ES2778028T3/en active Active
- 2013-05-17 EP EP13790927.1A patent/EP2850212B1/en active Active
- 2013-05-17 AU AU2013262435A patent/AU2013262435B2/en active Active
- 2013-05-17 EP EP19199179.3A patent/EP3608421B1/en active Active
- 2013-05-17 US US14/401,157 patent/US10941449B2/en active Active
- 2013-05-17 WO PCT/AU2013/000519 patent/WO2013170314A1/en active Application Filing
- 2013-05-17 EP EP22180135.0A patent/EP4116437A1/en active Pending
- 2013-05-17 DK DK19199179.3T patent/DK3608421T3/en active
-
2015
- 2015-09-22 HK HK15109289.4A patent/HK1208709A1/en unknown
-
2019
- 2019-02-28 AU AU2019201419A patent/AU2019201419B2/en active Active
-
2021
- 2021-02-05 US US17/169,285 patent/US20210254169A1/en not_active Abandoned
- 2021-02-05 US US17/169,293 patent/US20210262038A1/en not_active Abandoned
- 2021-06-11 AU AU2021203906A patent/AU2021203906B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3608421B1 (en) | 2022-06-29 |
| EP4116437A1 (en) | 2023-01-11 |
| EP2850212A1 (en) | 2015-03-25 |
| US20210254169A1 (en) | 2021-08-19 |
| EP3608421A1 (en) | 2020-02-12 |
| WO2013170314A1 (en) | 2013-11-21 |
| US20210262038A1 (en) | 2021-08-26 |
| AU2013262435B2 (en) | 2019-03-07 |
| DK3608421T3 (en) | 2022-09-05 |
| EP2850212A4 (en) | 2016-06-01 |
| AU2019201419A1 (en) | 2019-03-21 |
| US10941449B2 (en) | 2021-03-09 |
| US20150152505A1 (en) | 2015-06-04 |
| AU2021203906B2 (en) | 2023-08-31 |
| AU2013262435A1 (en) | 2014-12-04 |
| HK1208709A1 (en) | 2016-03-11 |
| AU2019201419B2 (en) | 2021-08-12 |
| ES2778028T3 (en) | 2020-08-07 |
| EP2850212B1 (en) | 2020-01-01 |
| AU2021203906A1 (en) | 2021-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2850212T3 (en) | Method of screening for colorectal cancer | |
| HK1217218A1 (en) | Biomarkers for colorectal cancer | |
| SG11201604743QA (en) | Cancer detection method using sense of smell of nematode | |
| DK3043816T3 (en) | ANTI-B7-H1 ANTIBODIES FOR TREATMENT OF TUMORS | |
| CU24158B1 (en) | 1-KESTOSA OBTAINING METHOD | |
| BR112014027626A2 (en) | apparatus and method of formation and object thus made | |
| HK1218014A1 (en) | Methods for indirect determination of reference intervals | |
| IL237436A0 (en) | Method for screening cancer | |
| DK3010352T3 (en) | METHOD OF PREPARING FEED ADDITION | |
| DK2914739T3 (en) | COMBINATIONS OF BIOMARKERS FOR COLORECTAL TUMORS | |
| DK2876447T3 (en) | Method for detecting cancer | |
| GB201322365D0 (en) | Improved method for repid analysis of gold | |
| HK1213634A1 (en) | Methods of detecting cancer | |
| HK1219489A1 (en) | Methods of treating colorectal cancer | |
| DK2849760T3 (en) | PROCEDURES FOR OLIGONUCLEOTIDE-CHELATE COMPLEX | |
| BR112014011008A2 (en) | cancer treatment quantification method | |
| PL3071969T3 (en) | Method of analysis | |
| BR112015002542A2 (en) | characterization method of an object | |
| BR112016002104A2 (en) | 3-oxopent-4-enoyl-coa synthesis method | |
| DK3016682T3 (en) | METHODS FOR TREATING CANCER | |
| EP2972376A4 (en) | Methods for determining prognosis of colorectal cancer | |
| FR2967165B1 (en) | METHOD OF SCREENING COLORECTAL CANCER | |
| EP2921854A4 (en) | Method for screening substance controlling function of xkr8 | |
| DK2840900T3 (en) | Method of baking | |
| HK1209330A1 (en) | Chemoprevention of colorectal cancer |